An analysis by the International Narcotics Control Board (INCB) concludes that most of the World Health Organization’s (WHO) cannabis scheduling recommendations would either have little impact on international drug controls or actually tighten requirements. The analysis was provided to member states shortly before the start of the first in a series of UN meetings. The WHO recommendations are often celebrated as a positive step toward the easing of the international control of cannabis, which would be a positive development for the industry. But regarding practical implications in the level of international control, the INCB document found that, if adopted two recommendations would imply no meaningful change and two others would mean more control for pure THC.